New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Ocugen, Inc. (OCGN) vs Q32 Bio Inc. (QTTB)

Ocugen, Inc. and Q32 Bio Inc. are both Biotechnology companies. Ocugen, Inc. and Q32 Bio Inc. are of similar size ($253.8M and $248.6M). Ocugen, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Ocugen, Inc. grew revenue faster over the last twelve months: −11.0% against −307.3%. Q32 Bio Inc. has the higher net margin (808.0% vs −1,367.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Q32 Bio Inc. leads on 10 and Ocugen, Inc. on 3.

Valuation

Metric OCGN QTTB Biotechnology median
P/E n/m 2.49 8.49
P/S 54.65 n/m 8.56
P/B n/m 0.99 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA n/m 0.15 0.69
EV/Sales 37.40 0.78 8.00
Earnings yield (25.97%) 40.19% (35.81%)
Free cash flow yield (24.47%) (7.04%) (25.41%)

Profitability

Metric OCGN QTTB Biotechnology median
Gross margin 100.00% 100.00% 70.18%
Operating margin (1,444.47%) 725.53% 0.00%
Net margin (1,367.61%) 808.04% 0.00%
Free cash flow margin (1,337.16%) 280.89% 0.00%
Return on equity 923.92% 23.96% (51.58%)
Return on assets (78.91%) 18.17% (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCGN QTTB Biotechnology median
Revenue growth (TTM) (11.01%) (307.33%) 7.20%
EPS growth (last fiscal year) (15.00%) 136.78% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric OCGN QTTB Biotechnology median
Debt to equity (0.10) 0.00 0.00
Current ratio 0.77 56.34 4.79
Net debt to EBITDA (0.17) (2.21) 1.01

Dividend

Metric OCGN QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OCGN QTTB Biotechnology median
Market cap 248.64m 253.75m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack